Parkinson's Disorder Research Laboratory, Iowa Center for Advanced Neurotoxicology, Department of Biomedical Sciences, Iowa State University, Ames, IA 50011, USA.
Neurotoxicology. 2010 Sep;31(5):555-61. doi: 10.1016/j.neuro.2009.12.003. Epub 2009 Dec 11.
Parkinson's disease (PD) is a common neurodegenerative movement disorder characterized by extensive degeneration of dopaminergic neurons in the nigrostriatal system. Neurochemical and neuropathological analyses clearly indicate that oxidative stress, mitochondrial dysfunction, neuroinflammation and impairment of the ubiquitin-proteasome system (UPS) are major mechanisms of dopaminergic degeneration. Evidence from experimental models and postmortem PD brain tissues demonstrates that apoptotic cell death is the common final pathway responsible for selective and irreversible loss of nigral dopaminergic neurons. Epidemiological studies imply both environmental neurotoxicants and genetic predisposition are risk factors for PD, though the cellular mechanisms underlying selective dopaminergic degeneration remain unclear. Recent progress in signal transduction research is beginning to unravel the complex mechanisms governing dopaminergic degeneration. During the 12th International Neurotoxicology meeting, discussion at one symposium focused on several key signaling pathways of dopaminergic degeneration. This review summarizes two novel signaling pathways of nigral dopaminergic degeneration that have been elucidated using neurotoxicity models of PD. Dr. Anumantha Kanthasamy described a cell death pathway involving the novel protein kinase C delta isoform (PKCdelta) in oxidative stress-induced apoptotic cell death in experimental models of PD. Dr. Ajay Rana presented his recent work on the role of mixed lineage kinase-3 (MLK3) in neuroinflammatory processes in neurotoxic cell death. Collectively, PKCdelta and MLK3 signaling pathways provide new understanding of neurodegenerative processes in PD, and further exploration of these pathways may translate into effective neuroprotective drugs for the treatment of PD.
帕金森病(PD)是一种常见的神经退行性运动障碍,其特征是黑质纹状体系统中的多巴胺能神经元广泛退化。神经化学和神经病理学分析清楚地表明,氧化应激、线粒体功能障碍、神经炎症和泛素蛋白酶体系统(UPS)的损伤是多巴胺能神经元退化的主要机制。来自实验模型和 PD 脑标本的证据表明,细胞凋亡是负责黑质多巴胺能神经元选择性和不可逆转丧失的常见最终途径。流行病学研究表明,环境神经毒素和遗传易感性是 PD 的危险因素,尽管导致选择性多巴胺能退化的细胞机制仍不清楚。信号转导研究的最新进展开始揭示调控多巴胺能退化的复杂机制。在第 12 届国际神经毒理学会议上,一个专题讨论会上的讨论集中在几个与 PD 神经毒性模型相关的多巴胺能退化的关键信号通路。这篇综述总结了两种新的黑质多巴胺能退化信号通路,这些通路是使用 PD 的神经毒性模型阐明的。Anumantha Kanthasamy 博士描述了一种涉及新型蛋白激酶 C 德尔塔同工型(PKCdelta)的细胞死亡途径,该途径涉及 PD 实验模型中的氧化应激诱导的凋亡细胞死亡。Ajay Rana 博士介绍了他最近关于混合谱系激酶-3(MLK3)在神经毒性细胞死亡中的神经炎症过程中的作用的工作。总的来说,PKCdelta 和 MLK3 信号通路为 PD 中的神经退行性过程提供了新的认识,对这些通路的进一步探索可能会转化为治疗 PD 的有效神经保护药物。